Galera Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Galera Therapeutics

09/08/2022 16:50

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted
loss of 54 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 53 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Galera Therapeutics Inc's reported EPS for the quarter was
a
loss of 54 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Galera Therapeutics Inc shares had fallen by 6.2% this
quarter and lost 73.4% so far this year.
    * The company reported a quarterly loss of $14.58 million.
    * Wall Street's median 12-month price target for Galera
Therapeutics Inc is $12.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 03:50 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.53          -0.54          Missed
 Mar. 31 2022      -0.57          -0.58          Missed
 Dec. 31 2021      -0.75          -0.64          Beat
 Sep. 30 2021      -0.77          -0.86          Missed